@_txss.luis: #crash #comebackseason #trusttheprocess

ℒ𝓊𝒾𝓈❄️
ℒ𝓊𝒾𝓈❄️
Open In TikTok:
Region: US
Friday 06 November 2026 00:57:17 GMT
51699
3181
132
336

Music

Download

Comments

co.mar16
co.mar16 :
neta i wouldn’t wish this shi on anyone 😞
2026-11-06 03:48:35
85
oc.emanuel
￴ ￴￴ ￴￴ ￴￴￴ ￴￴￴￴￴ ￴￴ ￴￴ :
Truck looked new to fah
2026-11-06 02:08:23
52
already21k
Zenyboy171 :
I'm there too pri trust we got this 😞🙏🏽
2026-11-06 04:15:43
3
z71ganzito
GanzitoZ71🐥 :
Happens to the best of us 😔
2026-11-06 03:26:13
10
e3799b
e3799b :
Bring her back pa I did
2026-11-06 10:35:36
0
ivancito13cfm
Ivan Angulo :
nooooooooooʻoooooooo
2026-11-06 06:41:28
0
085.ale
𝔄𝔩𝔢𝔵 :
I'm there too bro, trust we got this 😞🙏🏽
2026-11-06 04:12:53
1
user.snqtueio
Randyhdz_367 :
You will come back stronger pa🤙🏼
2026-11-06 04:07:01
2
sadndsexccc
sadndsexc :
i know that all too well
2026-11-06 02:54:06
5
ntddx3ni
. :
💔🫩
2026-11-06 04:21:09
1
nbsjoel02
Joel Ojeda :
Me too 😔
2026-11-06 04:08:10
1
.lilmama03
.angie🖤 :
Ay at least It’s not this
2026-11-06 05:08:01
0
chino_lowks1
chino_lowks1 :
I got a door delete
2026-11-06 05:18:43
0
montoya_xll
montoya_xll :
Los recuerdos
2026-11-06 05:00:43
2
pablo.hinojosa10
Pablo Hinojosa :
🥺
2026-11-06 04:34:02
2
exoticsaid
POV :
😔
2026-11-06 03:25:40
3
paletxso
🍭 :
Hd bubble eye front end otw😳
2026-11-06 03:40:59
3
j.nathxnn
J :
Been through this be ready to have problems in the future even if you fix it
2026-11-06 04:06:05
2
al3jandr0.21
𝓐﹅⋆୨୧𓂅ଘ⊹ǂꕤ :
Bro will bounce back trust [Pray]
2026-11-06 03:44:02
1
To see more videos from user @_txss.luis, please go to the Tikwm homepage.

Other Videos

Researchers at Columbia turned a gut probiotic into a living drug factory — and it eliminated tumors in 43% of treated mice with a single injection.   Chemotherapy and immunotherapy each have a fundamental flaw: chemotherapy floods the entire body, not just the tumor, while immunotherapy can trigger dangerous, body-wide inflammation. Immunologist Nicholas Arpaia's team at Columbia engineered Escherichia coli Nissle, a bacterium already used as a probiotic, to solve both problems at once by concentrating the attack directly inside the tumor.   The bacteria were built to do three things simultaneously. First, they convert a harmless prodrug called 5-FC into active chemotherapy, but only once inside the tumor — turning the tumor itself into the site of drug production rather than exposing the whole body. Second, they produce an IL-15 superagonist, a compound that recruits and activates cancer-fighting immune cells. Third, they release a nanobody that blocks PD-L1, a protein tumors use to disable incoming immune attacks — a localized version of the same mechanism behind major checkpoint-inhibitor cancer drugs.   In mice with established colorectal tumors, a single injection of the engineered bacteria, followed by doses of the prodrug, outperformed either the chemotherapy-producing or immune-stimulating bacteria used alone. Three of seven tumors disappeared completely — a 43% full-response rate — and researchers saw early signs the effect wasn't staying confined to the treated tumor alone.   The approach remains preclinical, tested only in mice, with no human trial data yet. But colorectal cancer rates are climbing, especially among younger adults, for reasons still under investigation — and a treatment engineered to attack only where the tumor lives, rather than the whole body, addresses exactly the tradeoff current therapies still can't avoid.   source: Arpaia, N., et al. (2026). Engineered bacterial consortium for localized chemo-immunotherapy of colorectal cancer. Science Translational Medicine.
Researchers at Columbia turned a gut probiotic into a living drug factory — and it eliminated tumors in 43% of treated mice with a single injection.   Chemotherapy and immunotherapy each have a fundamental flaw: chemotherapy floods the entire body, not just the tumor, while immunotherapy can trigger dangerous, body-wide inflammation. Immunologist Nicholas Arpaia's team at Columbia engineered Escherichia coli Nissle, a bacterium already used as a probiotic, to solve both problems at once by concentrating the attack directly inside the tumor.   The bacteria were built to do three things simultaneously. First, they convert a harmless prodrug called 5-FC into active chemotherapy, but only once inside the tumor — turning the tumor itself into the site of drug production rather than exposing the whole body. Second, they produce an IL-15 superagonist, a compound that recruits and activates cancer-fighting immune cells. Third, they release a nanobody that blocks PD-L1, a protein tumors use to disable incoming immune attacks — a localized version of the same mechanism behind major checkpoint-inhibitor cancer drugs.   In mice with established colorectal tumors, a single injection of the engineered bacteria, followed by doses of the prodrug, outperformed either the chemotherapy-producing or immune-stimulating bacteria used alone. Three of seven tumors disappeared completely — a 43% full-response rate — and researchers saw early signs the effect wasn't staying confined to the treated tumor alone.   The approach remains preclinical, tested only in mice, with no human trial data yet. But colorectal cancer rates are climbing, especially among younger adults, for reasons still under investigation — and a treatment engineered to attack only where the tumor lives, rather than the whole body, addresses exactly the tradeoff current therapies still can't avoid.   source: Arpaia, N., et al. (2026). Engineered bacterial consortium for localized chemo-immunotherapy of colorectal cancer. Science Translational Medicine.

About